| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,860 |
3,605 |
$273K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,166 |
2,847 |
$162K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,715 |
1,715 |
$160K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,767 |
4,400 |
$132K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,045 |
2,037 |
$129K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,576 |
776 |
$19K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,732 |
1,581 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
734 |
720 |
$9K |
| 99058 |
|
176 |
156 |
$7K |
| 81025 |
|
601 |
576 |
$4K |
| 81002 |
|
1,134 |
1,092 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
340 |
335 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
99 |
98 |
$3K |
| 99441 |
|
27 |
26 |
$424.96 |
| 87210 |
|
66 |
66 |
$192.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
13 |
$21.76 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
12 |
$6.50 |
| 99051 |
|
437 |
414 |
$0.00 |
| 99072 |
|
135 |
121 |
$0.00 |